Gubra A/S, empresa biotecnológica, se centra en la investigación preclínica por contrato y el descubrimiento de fármacos basados en péptidos para enfermedades metabólicas y fibróticas en Europa, Norteamérica e internacionalmente.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.